http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#Head
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#assertion
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#provenance
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#pubInfo
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#assertion
https://uts.nlm.nih.gov/uts/umls/concept/C0429964
http://wordnet-rdf.princeton.edu/lemma/integrate
https://uts.nlm.nih.gov/uts/umls/concept/C0011777
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#provenance
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-12-16T19:31:00.153611
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC project version 2
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#version
http://www.w3.org/ns/prov#value
2
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT
http://www.w3.org/2000/01/rdf-schema#label
into the final PK / PD model, ", where dexamethasone ( DEX ) exerted dexamethasone ( DEX ) s antitumor efficacy by inhibiting the proliferation of tumor cells", enhanced dexamethasone ( DEX ) responses by decreasing the sensitivity parameter EC(50 )
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
38
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE
http://www.w3.org/2000/01/rdf-schema#label
integrated
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION
http://www.w3.org/2000/01/rdf-schema#label
[154]
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT
http://www.w3.org/2000/01/rdf-schema#label
The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
134
http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:wdxnfuun&rows=50
wdxnfuun
http://www.w3.org/2000/01/rdf-schema#SENTENCE
http://www.w3.org/2000/01/rdf-schema#label
The PK model of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) as well as that of dexamethasone (DEX) with a time-dependent clearance were integrated into the final PK/PD model both using Hill’s function, where dexamethasone (DEX) exerted dexamethasone (DEX)'s antitumor efficacy by inhibiting the proliferation of tumor cells, and dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) enhanced dexamethasone (DEX) responses by decreasing the sensitivity parameter EC(50).
http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:wdxnfuun-TRIPLE-ABSTRACT-10
wdxnfuun-TRIPLE-ABSTRACT-10
https://uts.nlm.nih.gov/uts/umls/concept/C0011777
http://www.w3.org/2000/01/rdf-schema#label
dexamethasone
https://uts.nlm.nih.gov/uts/umls/concept/C0429964
http://www.w3.org/2000/01/rdf-schema#label
dependent
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#pubInfo
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#sig
http://purl.org/nanopub/x/hasSignature
ceew7126tkpogULIPni1Lx4m7e2q05UVy+69MowCK3gws0Nrexx3cZhmJ3P/aamGf0cI/f3ScKH+IZbRnTW/uoTkPkW1NlehpNkzucdfaIuw8S2ax5MHDUC001y9QTvgBTBTSQpgoJVOUyX4/VDR9O7G34JV7ebDE5U+ZfaLqGQ=
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.w3.org/ns/prov#generatedAtTime
2021-12-16T19:31:00.153611
http://purl.org/np/RA49YG5OyeuxUriLLpUXtDsGiE71Y3UPxtFU1nMvnvASk
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-8954-0470